Komori
Chordia Therapeutics (190A) · RiskRestated

Business Environment Risks from Uncertainty over Political Instability, Conflicts, and U.S. Trade Policy

First written in FY2025-H1. 2 of 3 entries say "Restated". Latest entry: 2026-10-15.

3entries
2years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2025-H1 – 2026-10-152025: 120252026: 22026
Same theme, other companies
Business Uncertainty Stemming from Protectionist Trade Policies and Geopolitical ConditionsA theme 364 companies write about · 371 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2022: 106 of 135 companies on the "Worse" side.

65 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 372 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-15RestatedEarnings

    「なお、現下の中東情勢を含む地政学的リスクについて、現時点において当社の事業運営及び業績に重要な影響を及ぼす事象は認識しておりません。」

    地政学的リスクやサプライチェーンへの影響は記載されたが、現時点で事業運営・業績への重要な影響は認識されていないとの説明が再確認された。
  2. FY2026-H1RestatedAnnual report

    「The recent increase in geopolitical risks has affected supply chains and resource prices, further increasing uncertainty across corporate activities. However, regarding geopolitical risks, including the current situation in the Middle East, we are not currently aware of any event that is having a material impact on our business operations or performance.」

    Geopolitical risks and their impact on supply chains continued to be described as external environment factors, but no material impact on the company's business operations or performance has been identified at this time.
  3. FY2025-H1First statedAnnual report

    「The outlook remains uncertain due to political instability, including changes of government in major developed countries, the ongoing conflicts in Ukraine and the Middle East, and uncertainty over U.S. trade policy.」

    Political instability, conflicts and uncertainty over U.S. trade policy were described as external business environment factors during the interim accounting period. No material changes were reported in the formal business and other risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Chordia Therapeutics's next results are scheduled for 2026-10-15. Read the earnings preview It last moved in the Earnings of 2026-10-15: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.